• Home
  • Disease & Drugs
  • Wellness
  • Health Tidings
  • Whitepapers
  • Newsletter
  • About
  • Home
  • Disease & Drugs
  • Wellness
  • Health Tidings
  • Whitepapers
  • Newsletter
  • About
  • Home
  • Disease & Drugs
  • Wellness
  • Health Tidings
  • Whitepapers
  • Newsletter
  • About

Home

Monthly Archives: July 2025

ChatGPT Image Jul 7, 2025, 01_46_40 PM

Look Alike & Sound Alike Medicines: An Emerging Challenge in Patient Safety

July 7, 2025
by official.ajinkya11@gmail.com Disease & Drugs

07 July 2025Category: Patient Safety Initiatives IClinical Practice & Prescribing Safety IMedication SafetyWritten By: Dr. Srivatsan Suresh (PharmD) Around the world, Look Alike & Sound Alike drugs (LASA) are a k ...

Read More
0
guduchi

Health Benefits of Tinospora Cordifolia (Guduchi /Giloy/Gulvel)

July 6, 2025
by official.ajinkya11@gmail.com Wellness

06 July 2025Category: Ayurvedic & Integrative Therapeutics I Traditional Medicine in Modern Health ResearchWritten By: Shweta Rajguru (PharmD, purs.)Reviewed By: Ayurvedacharya Dr. Gaurav Pahare BAMS Granniezgreen.c ...

Read More
0
TKR_11zon

How Robotic Technology is Transforming Knee Replacement Surgery

July 1, 2025
by official.ajinkya11@gmail.com Disease & Drugs

01 July 2025Category: Surgical Technology I Robotic Surgery IRobotic Knee Surgery Medically Reviewed By: Dr. Dinesh Patil (MBBS, D-Ortho)Knee and Hip Arthroplasty specialist surgeonAssisted By: Dewanshee Ingale ciocente ...

Read More
0
  • First
  • Previous
  • 1
  • 2

Recent Posts

  • FDA Halts Sarepta Therapeutics’ AAVrh74 based Gene Therapy Trials after Third Death from Liver Failure
  • “Repurposing Fenbendazole in Oncology: Hype vs. Hope in the Context of the ‘Joe Tippens Protocol'”
  • Topline Phase 3 Results of Hengrui Pharma and Kailera Therapeutics’ Dual Agonist HRS9531 Shows Promising Weight Loss: A Rising Competitor to Zepbound?
  • “FDA raises Ocular Toxicity Concerns over GSK’s Blenrep (Belantamab Mafodotin): A Setback for Multiple Myeloma Hope”
  • Sun Pharma Launches LEQSELVI™ in the U.S. for Severe Alopecia Areata after Patent Settlement

Recent Comments

No comments to show.

Archives

  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025

About Us

  • About Us
  • Internship with us
  • Terms and Conditions

Categories

  • Clinical Trails
  • Disease & Drugs
  • Food
  • Health Tidings
  • Lifestyle
  • New Drug Approval
  • Research
  • Wellness
  • Women & Child Health

Pharmacally a brand of

MedCognize Communications (OPC) Pvt. Ltd.

Gat No. 405, Plot No. 17, Post-Nighoje, Near Faith Automation,

Opp. Anjali T Precision, Chakan Industrial Area, Pune 410501

Maharashtra, India

Contact No. - +91 9960598036

Email - contactus@pharmacally.com

  • About Us
  • Advisory Panel (Medical Experts)
  • About Founder
  • Source of Information

Follow Us -

Facebook Whatsapp Linkedin X-twitter
  • Internship with us
  • Advertise with us
  • Privacy Policy
  • Terms & Conditions

Subscribe to Newsletter -

SUBSCRIBE

Follow Us -

Facebook Whatsapp Linkedin X-twitter

Disclaimer: The content provided on the website is for information purposes only and is not intended as medical advice, diagnosis or treatment. Always seek doctors and other health provider’s advice in person regarding your any medical query or condition.

Copyright © 2025 Pharmacally | Designed by TEXPERT MENTOR

Shopping Basket